ScienceOpen:
research and publishing network
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
My ScienceOpen
Sign in
Register
Dashboard
Blog
About
Search
Advanced search
My ScienceOpen
Sign in
Register
Dashboard
Search
Search
Advanced search
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
Blog
About
4
views
0
references
Top references
cited by
1
0 reviews
Review
0
comments
Comment
0
recommends
+1
Recommend
0
collections
Add to
0
shares
Share
Twitter
Sina Weibo
Facebook
Email
3,282
similar
All similar
Record
: found
Abstract
: not found
Article
: not found
MDMA expected to get US approval as therapy for PTSD
Author(s):
J. A. Murugesu
Publication date:
2023
Journal:
New Scientist
Read this article at
ScienceOpen
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Related collections
Psychology by AKJournals
Data availability:
ScienceOpen disciplines:
Evolutionary Biology
,
Medicine
,
Psychology
,
Educational research & Statistics
,
Social & Behavioral Sciences
Comments
Comment on this article
Sign in to comment
Similar content
3,282
Australia's approval of MDMA and psilocybin for PTSD and depression is premature, say critics.
Authors:
Bianca Nogrady
Cocaine, metamfetamine, and MDMA abuse: the role and clinical importance of neuroadaptation.
Authors:
D Seger
The spatial epidemiology of cocaine, methamphetamine and 3,4-methylenedioxymethamphetamine (MDMA) use: a demonstration using a population measure of community drug load derived from municipal wastewater.
Authors:
D Sudakin
,
Craig Field
,
Aurea Chiaia
…
See all similar
Cited by
1
Critical review of 3,4-methylenedioxymethamphetamine (MDMA)-assisted therapy for posttraumatic stress disorder: Unanswered questions and future directions
Authors:
Alex P. Hood
,
Chris E. Corlett
,
Cameron T. Alldredge
…
See all cited by